UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Annals of oncology, 2018-10, Vol.29, p.viii102-viii103

2018

Volltextzugriff (PDF)

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

British journal of cancer, 2014-06, Vol.110 (12), p.2847-2854

2014

Volltextzugriff (PDF)

Evaluation of the Efficacy of Fulvestrant in Locally Advanced and Metastatic Breast Cancer in a Single Breast Unit

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-06, Vol.29 (6), p.e100-e101

2017

Volltextzugriff (PDF)

The Addition of Whole-body MRI to Body CT Scans Alters Systemic Anti-cancer Treatment Decisions in Metastatic Breast Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-06, Vol.29 (6), p.e100-e100

2017

Volltextzugriff (PDF)

Whole Body Diffusion-weighted MRI in Metastatic Breast Cancer Patients: The Luton and Dunstable Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-05, Vol.28 (5), p.e4-e4

2016

Volltextzugriff (PDF)

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

The lancet oncology, 2015-03, Vol.16 (3), p.266-273

2015

Volltextzugriff (PDF)

Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006-08, Vol.18 (6), p.453-458

2006

Volltextzugriff (PDF)

228 Evaluation of Megasterol Acetate in Locally Advanced and Metastatic Breast Cancer in the era of Aromatase Inhibitors

European journal of cancer (1990), 2012-03, Vol.48, p.S109-S109

2012

Volltextzugriff (PDF)

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer

British journal of cancer, 2006-12, Vol.95 (12), p.1683-1688

2006

Volltextzugriff (PDF)

Breast Cancer Multidisciplinary Team Adjuvant Therapy Decision Making and Adjuvant! Online

Clinical oncology (Royal College of Radiologists (Great Britain)), 2010-02, Vol.22 (1), p.87-88

2010

Volltextzugriff (PDF)

It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-09, Vol.28 (9), p.594-596

2016

Volltextzugriff (PDF)

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom

British journal of radiology, 2015-01, Vol.88 (1056), p.20150453-20150453

2015

Volltextzugriff (PDF)

Audit of Bone-modifying Treatment in Metastatic Breast Cancer at a Single Breast Unit

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-06, Vol.30 (6), p.e46-e47

2018

Volltextzugriff (PDF)

Abstract P5-01-01: Adding whole-body MRI to body CT scans when evaluating response to systemic anti-cancer therapies alters treatment decisions in metastatic breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-01-01

2017

Volltextzugriff (PDF)

321PResponse evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Evaluation and Management of the Complications of Lung Cancer Treatment

Seminars in respiratory and critical care medicine, 2000, Vol.21 (Number 05), p.451-462

2000

Volltextzugriff (PDF)

Abstract P4-01-07: Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-01-07

2013

Volltextzugriff (PDF)

Abstract P4-01-08: Assessing response in breast cancer with dynamic contrast enhanced magnetic resonance imaging: Are signal intensity time curves adequate?

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-01-08

2013

Volltextzugriff (PDF)

Adjuvant therapy decisions in breast cancer: comparison of a multi disciplinary team's decisions with the recommendations of web-based computer programme “Adjuvant Online”

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2117

2009

Volltextzugriff (PDF)

Imaging tumor hypoxia with BOLD MRI in primary breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13526-e13526

2010

Volltextzugriff (PDF)

Greater Anti-Angiogenic Effects with Docetaxel Compared with Anthracyclines in the Neoadjuvant Treatment of Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5013-5013

2009

Volltextzugriff (PDF)

Dynamic Contrast-Enhanced MRI as a Predictor of Patient Outcome with Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.1092-1092

2009

Volltextzugriff (PDF)

Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.667-667

2006

Volltextzugriff (PDF)

Do pre-treatment haemoglobin levels predict for response to neoadjuvant chemotherapy in breast cancer?

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.809-809

2005

Volltextzugriff (PDF)

Evaluation of tumour microvessel density & pericyte coverage index following neoadjuvant chemotherapy in primary breast cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.655-655

2005

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

Evaluation of the Efficacy of Fulvestrant in Locally Advanced and Metastatic Breast Cancer in a Single Breast Unit

The Addition of Whole-body MRI to Body CT Scans Alters Systemic Anti-cancer Treatment Decisions in Metastatic Breast Cancer

Whole Body Diffusion-weighted MRI in Metastatic Breast Cancer Patients: The Luton and Dunstable Experience

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

228 Evaluation of Megasterol Acetate in Locally Advanced and Metastatic Breast Cancer in the era of Aromatase Inhibitors

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer

Breast Cancer Multidisciplinary Team Adjuvant Therapy Decision Making and Adjuvant! Online

It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom

Audit of Bone-modifying Treatment in Metastatic Breast Cancer at a Single Breast Unit

Abstract P5-01-01: Adding whole-body MRI to body CT scans when evaluating response to systemic anti-cancer therapies alters treatment decisions in metastatic breast cancer

321PResponse evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Evaluation and Management of the Complications of Lung Cancer Treatment

Abstract P4-01-07: Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer

Abstract P4-01-08: Assessing response in breast cancer with dynamic contrast enhanced magnetic resonance imaging: Are signal intensity time curves adequate?

Adjuvant therapy decisions in breast cancer: comparison of a multi disciplinary team's decisions with the recommendations of web-based computer programme “Adjuvant Online”

Imaging tumor hypoxia with BOLD MRI in primary breast cancer

Greater Anti-Angiogenic Effects with Docetaxel Compared with Anthracyclines in the Neoadjuvant Treatment of Breast Cancer

Dynamic Contrast-Enhanced MRI as a Predictor of Patient Outcome with Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response

Do pre-treatment haemoglobin levels predict for response to neoadjuvant chemotherapy in breast cancer?

Evaluation of tumour microvessel density & pericyte coverage index following neoadjuvant chemotherapy in primary breast cancer

Suchergebnisse filtern